TAAR1 and Alzheimer disease: In conclusion, the present study showed the role of TAAR1 in modulating NMDA receptor expression and localization and suggests that TAAR1 agonists might be promising tools to counteract cognitive dysfunction in disorders involving amyloid accumulation, such as AD.